Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

Share Price is delayed by 15 minutes
Get Live Data
2,730.00    -85.00 (-3.02%)
Bid:
2,695.00
Ask:
2,790.00
Spread: 95.00 (3.525%)
Market Cap: £1.29b
RHIM Live PriceLast checked at - London Stock Exchange

Intraday RHI Magnesita Share Chart

Q1 Trading Update

29 Apr 2026 07:00

RNS Number : 2961C
RHI Magnesita N.V.
29 April 2026
 

29 April 2026

RHI Magnesita N.V.

("RHI Magnesita" or "the Group")

Q1 2026 TRADING UPDATE

Continued progress in a volatile world

RHI Magnesita, the leading global supplier of high-grade refractory products, systems and solutions, today provides an update on trading for the three months ended 31 March 2026 ("Q1").

· Global demand for steel and industrial refractories was slightly weaker than prior year with regional performance varying.

· Adjusted EBITA increased meaningfully year-on-year, supported by continued execution of management-led self-help initiatives across pricing, cost discipline, network optimisation and enhanced supply chain agility.

· Full-year guidance reconfirmed: adjusted EBITA of approximately €435 million on a constant currency basis (approximately €400 million including foreign exchange headwinds).

· Strong full-year cash generation expected to support further deleveraging to approximately 2.6x by year-end.

Q1 trading

Demand for refractories weakened in steel markets in Europe, Middle East and LATAM and were at expected levels in other regions. RHI Magnesita steel sales volumes were broadly in line with Q1 2025, with moderate pricing benefits realised. Industrial refractory demand decreased slightly in cement and industrial projects.

Strong profit contributions from North America and Latin America supported Q1 earnings, while India, China & East Asia and META (Middle East, Türkiye & Africa) performed in line with expectations. Europe & CIS underdelivered, primarily due to volume shifts from Q1 to Q2. Performance in Europe has the potential to improve over the remainder of the year, supported by cost reduction measures and early signs of recovery in the Industrial business, particularly in non-ferrous metals.

At the end of Q1 2026, the Group announced a review of its production footprint in France, including the potential closure of one plant and the conversion of another into a circular economy site. This forms part of the Network Optimisation Programme Europe and is intended to enhance competitiveness and improve operational efficiency.

Adjusted EBITA increased by approximately 15% year-on-year (+46% on a constant currency basis), while reported EBIT increased by 25% year-on-year (+84% on a constant currency basis). The improvement was primarily driven by sustained cost discipline and the continued benefits of management-led self-help measures implemented in 2025 and 2026.

The conflict in the Middle East did not have a material impact on the Group's performance in Q1 but depressed sales volumes in March in the region. While certain local customers were significantly affected, the Group's overall exposure to the region remains limited. All impacted shipments were successfully redirected via alternative routes to serve customers both regionally and globally, with service levels maintained high above industry standards. The Q2 order intake remains robust.

The longer-term impact of the conflict remains uncertain. The Group will continue to execute management led self-help measures to mitigate potential headwinds.

Customers across all regions continued to benefit from the Group's Local-for-Local strategy and modern supply chain capabilities despite significant global disruptions. Inflationary pressures arising from the conflict are being mitigated through the implementation of surcharges to offset higher energy, freight and raw material costs.

Financial position

Net debt at 31 March 2026 increased compared to year-end 2025, with leverage remaining broadly in line with recent levels. The increase was driven by higher working capital, reflecting a planned build-up in inventories ahead of anticipated stronger sales in Q2, particularly in industrial projects. This build-up is consistent with normal seasonal patterns and is expected to unwind over the remainder of the year, in line with full-year guidance on working capital intensity.

Leverage is expected to decline to around 2.6x by the end of 2026.

Full-year guidance reconfirmed

Demand across steel and industrial end markets remains resilient, albeit at subdued levels and regionally different. Against this backdrop, management continues to execute self-help measures which, together with momentum from the second half of 2025, support performance and underpin confidence in the Group's full-year guidance.

In line with previous guidance, adjusted EBITA for FY 2026 is expected to be approximately €435 million on a constant currency basis, or around €400 million after foreign exchange headwinds.

The Group expects to maintain strong cash generation, with cash conversion above 90% and continued deleveraging supported by disciplined working capital management. Net debt is projected to decline over the year, with leverage reducing to around 2.6x by year-end. M&A remains a core element of the strategy; however, no significant cash outflows related to transactions are anticipated in 2026.

Stefan Borgas, Chief Executive Officer, said:

"Despite a turbulent global economy in Q1, our performance demonstrates continued progress. Demand remains resilient overall, though slightly disappointing in major steel markets and with regional variations as expected. We have restored margins to acceptable levels, reflecting disciplined execution of our self-help measures.

We have also identified further opportunities in digitisation, plant network optimisation and SG&A efficiency, which are expected to support continued improvement and provide momentum over the next 18-24 months.

Our upgraded 4PRO full solutions value propositions to selected customers show encouraging feedback from leading, sophisticated customers in their markets.

We remain highly responsive to the evolving geopolitical backdrop, actively managing our supply chain to optimise costs and pricing. The increasing operational flexibility of our resilient Local-for-Local model, combined with rapidly advancing digital capabilities, further strengthens this adaptability.

Looking ahead, we remain confident that our proactive measures position us to manage ongoing market volatility."

The reported financial data in this trading update have not been audited.

Conference call

A conference call for analysts will be held at 8:15am UK time to discuss the trading update:

Webcast link: https://www.investis-live.com/rhimagnesita/69d52b0d3d1719000fc25143/mdgw

Dial in (listen only):

International: +44 20 3936 2999

UK toll free: 0800 358 1035

Access code: 856527

AGM

AGM - Further to the Notice of Meeting issued on 26 March 2026, the Company will hold its Annual General Meeting ("AGM') on 13 May 2026 at 14:00 CEST. Voting results from the AGM will be released shortly after the meeting.

 

For further enquiries, please contact:

Alexander Ordosch, Head of Investor Relations

Tel +43 699 1870 6162

E‐mail: Alexander.Ordosch@rhimagnesita.com

 

Media:

Hudson Sandler

Tel +44 020 7796 4133

E-mail: rhimagnesita@hudsonsandler.com

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with over 20,000 employees in 76 main production sites (including recycling facilities), 16 raw material sites and more than 70 sales offices. RHI Magnesita intends to leverage its leadership in terms of revenue, scale, product portfolio and diversified geographic presence to target strategically those countries and regions benefiting from more dynamic economic growth prospects.

RHI Magnesita offers investors EBITDA and free cash flow comparable to FTSE 100 peers, the highest free cash flow yield in the UK industrials sector, a compelling M&A growth story and high operational gearing to market recovery. The Group seeks to allocate capital to maximise value generation for shareholders. After maintenance capex and dividend, M&A, organic investments and buybacks compete for capital. The global refractory industry remains fragmented and the M&A pipeline presents an opportunity to continue a value-accretive consolidation strategy.

The Group is listed within the Equity Shares (Commercial Companies) category ("ESCC") of the Official List of the London Stock Exchange (symbol: RHIM) and is a constituent of the FTSE 250 index, with a secondary listing on the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBVLLLQZLBBBE
Date   Source Headline
1st Jun 20268:49 amRNSTotal Voting Rights
13th May 20264:07 pmRNSResult of AGM
1st May 20268:57 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSQ1 Trading Update
1st Apr 20269:11 amRNSTotal Voting Rights
26th Mar 20262:54 pmRNSNotice of AGM
10th Mar 202611:18 amRNSDirector/PDMR Shareholding
2nd Mar 20267:55 amRNSAnnual Financial Report
2nd Mar 20267:49 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNS2025 Full Year Results
13th Feb 20268:56 amRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
10th Dec 20259:10 amRNSDirectorate change
10th Nov 20257:00 amRNSTrading Update
7th Nov 202511:48 amRNSDirectorate change
3rd Nov 202511:54 amRNSDirectorate change
1st Oct 20257:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNS2025 Half Year Results
16th Jul 20257:00 amRNSNotice of Results
30th Jun 20258:29 amRNSDirector Declaration
2nd Jun 20258:53 amRNSTotal Voting Rights
29th May 20259:26 amRNSDirector/PDMR Shareholding
23rd May 20258:12 amRNSDirector Declaration
7th May 20254:11 pmRNSResult of AGM
7th May 20257:00 amRNSQ1 2025 Trading Update
1st May 20259:07 amRNSTotal Voting Rights
7th Apr 20253:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20254:17 pmRNSDirector/PDMR Shareholding
1st Apr 20254:49 pmRNSDirector/PDMR Shareholding
1st Apr 20259:13 amRNSTotal Voting Rights
28th Mar 20254:12 pmRNSDirector/PDMR Shareholding
27th Mar 20253:30 pmRNSNotice of AGM
27th Mar 20252:50 pmRNSDirectorate Change
24th Mar 202512:32 pmRNSNotice of AGM
7th Mar 202510:13 amRNS2025 Long Term Incentive Plan Awards
27th Feb 20257:00 amRNS2024 Full Year Results
17th Feb 20257:00 amRNSNotice of Results
3rd Feb 20259:11 amRNSTotal Voting Rights
28th Jan 20251:59 pmRNSCompletion of Resco transaction
2nd Jan 20257:00 amRNSTotal Voting Rights
28th Nov 202410:09 amRNSDirector/PDMR Shareholding
21st Nov 20249:03 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSQ3 2024 Trading Update
7th Oct 202410:10 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSTotal Voting Rights
27th Sep 202411:15 amRNSExercise of LTIP options by PDMR
19th Aug 202410:31 amRNSDirector/PDMR Shareholding
12th Aug 20242:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.